TFPT Human Pre-designed siRNA Set A contains three designed siRNAs for TFPT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TFR2 Human Pre-designed siRNA Set A contains three designed siRNAs for TFR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TFRC Human Pre-designed siRNA Set A contains three designed siRNAs for TFRC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TG Human Pre-designed siRNA Set A contains three designed siRNAs for TG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TGDS Human Pre-designed siRNA Set A contains three designed siRNAs for TGDS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TgENR-IN-1 (Compound 5a) is an inhibitor for Toxoplasma gondii enoyl reductase (TgENR), which inhibits 25% TgENR at 1 μM. TgENR-IN-1 exhibits toxicity with an IC50 of >10 μM in parasite tissue[1].

TGF-β1/Smad3-IN-1 (Compound 5aa) is an inhibitor of the TGF-β1/Smad3 signaling pathway(IC50=1.07 μM). TGF-β1/Smad3-IN-1 possesses antifibrotic activity and oral potency[1].

TGFA Human Pre-designed siRNA Set A contains three designed siRNAs for TGFA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TGFB1 Human Pre-designed siRNA Set A contains three designed siRNAs for TGFB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tgfb1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Tgfb1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tgfb1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Tgfb1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

TGFB1I1 Human Pre-designed siRNA Set A contains three designed siRNAs for TGFB1I1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TGFB2 Human Pre-designed siRNA Set A contains three designed siRNAs for TGFB2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tgfb2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Tgfb2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tgfb2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Tgfb2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

TGFB3 Human Pre-designed siRNA Set A contains three designed siRNAs for TGFB3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TGFBI Human Pre-designed siRNA Set A contains three designed siRNAs for TGFBI gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TGFBR1 Human Pre-designed siRNA Set A contains three designed siRNAs for TGFBR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tgfbr1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Tgfbr1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

TGFBR1 Rat Pre-designed siRNA Set A contains three designed siRNAs for TGFBR1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

TGFBR2 Human Pre-designed siRNA Set A contains three designed siRNAs for TGFBR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tgfbr2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Tgfbr2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tgfbr2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Tgfbr2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

TGFBR3 Human Pre-designed siRNA Set A contains three designed siRNAs for TGFBR3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tgfbr3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Tgfbr3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tgfbr3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Tgfbr3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

TGFBR3L Human Pre-designed siRNA Set A contains three designed siRNAs for TGFBR3L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TGFBRAP1 Human Pre-designed siRNA Set A contains three designed siRNAs for TGFBRAP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TGFβRI-IN-7 (Compound 2r) is a selective inhibitor of the TGFβ type II receptor (TGFβ RII) (IC50 = 4.1 μM). TGFβRI-IN-7 inhibits TGFβ signaling by promoting the proteolytic degradation of TGFβ RII. TGFβRI-IN-7 can block endothelial-to-mesenchymal transition and cell migration. TGFβRI-IN-7 can be used in cancer research[1].

TGFβRII-IN-2 (Compound 3n) is an inhibitor for transforming growth factor-β type II receptor (TGFβRII) with IC50 of 2.4 μM, which blocks endothelial-to-mesenchymal transition and cell migration in different cancer cell lines without perturbing the microtubule network[1].

TGIF1 Human Pre-designed siRNA Set A contains three designed siRNAs for TGIF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TGIF2 Human Pre-designed siRNA Set A contains three designed siRNAs for TGIF2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TGIF2LX Human Pre-designed siRNA Set A contains three designed siRNAs for TGIF2LX gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TGM1 Human Pre-designed siRNA Set A contains three designed siRNAs for TGM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TGM2 Human Pre-designed siRNA Set A contains three designed siRNAs for TGM2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TGM3 Human Pre-designed siRNA Set A contains three designed siRNAs for TGM3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TGM4 Human Pre-designed siRNA Set A contains three designed siRNAs for TGM4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TGM5 Human Pre-designed siRNA Set A contains three designed siRNAs for TGM5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TGM6 Human Pre-designed siRNA Set A contains three designed siRNAs for TGM6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TGM7 Human Pre-designed siRNA Set A contains three designed siRNAs for TGM7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TGOLN2 Human Pre-designed siRNA Set A contains three designed siRNAs for TGOLN2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TGS1 Human Pre-designed siRNA Set A contains three designed siRNAs for TGS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TH Human Pre-designed siRNA Set A contains three designed siRNAs for TH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TH6342 is a SAMHD1 modulator that binds to pretetrameric SAMHD1 and prevents its oligomerization and allosteric activation. SAMHD1 is a dNTP triphosphohydrolase and an HIV-1 restriction factor. SAMHD1 can limit the replication of retroviruses and DNA viruses and has antiviral effects. The inhibitory mechanism of TH6342 does not occupy the SAMHD1 nucleotide-binding pocket, gently binds […]

TH6342 is a SAMHD1 modulator that binds to pretetrameric SAMHD1 and prevents its oligomerization and allosteric activation. SAMHD1 is a dNTP triphosphohydrolase and an HIV-1 restriction factor. SAMHD1 can limit the replication of retroviruses and DNA viruses and has antiviral effects. The inhibitory mechanism of TH6342 does not occupy the SAMHD1 nucleotide-binding pocket, gently binds […]

TH6342 is a SAMHD1 modulator that binds to pretetrameric SAMHD1 and prevents its oligomerization and allosteric activation. SAMHD1 is a dNTP triphosphohydrolase and an HIV-1 restriction factor. SAMHD1 can limit the replication of retroviruses and DNA viruses and has antiviral effects. The inhibitory mechanism of TH6342 does not occupy the SAMHD1 nucleotide-binding pocket, gently binds […]

TH9619 is a MTHFD2 inhibitor with a IC50 value of 47 nM. TH9619 induces apoptosis by blocking the S phase. TH9619 has antitumor activity[1].

THADA Human Pre-designed siRNA Set A contains three designed siRNAs for THADA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.